Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis.
Saved in:
| Title: | Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis. |
|---|---|
| Authors: | Punglia, Rinaa S.1 rpunglia@partners.org, Burstein, Harold J.2, Winer, Eric P.2, Weeks, Jane C.2 |
| Source: | JNCI: Journal of the National Cancer Institute. 5/7/2008, Vol. 100 Issue 9, p642-648. 7p. 3 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 00278874 |
|---|---|
| DOI: | 10.1093/jnci/djn100 |
